Beijing Foyou Pharma (601089.SH): Libenzocaine cream has obtained drug registration certificate.
Fuyuan Pharmaceutical (601089.SH) has issued an announcement that its wholly-owned subsidiary Fuyuan Pharmaceutical Co., Ltd. Recently...
Beijing Foyou Pharma(601089.SH) announced that its wholly owned subsidiary, Fuyuan Pharmaceutical Co., Ltd. ("Fuyuan Pharma"), has recently received the "Drug Registration Certificate" for Lidocaine and Prilocaine Cream (specifications: 5g: Lidocaine 125mg and Prilocaine 125mg) from the National Medical Products Administration.
Related Articles
Hubei Jianxin Chemical (300107.SZ) controlling shareholder and concerted action person Huang Jiqin plans to reduce their shareholding by no more than 0.14%.
HORIZONROBOT-W (09660) has awarded the equivalent of 86,775,100 shares of Class B common stock as a reward.
Guangdong Leary New Material Technology Co.,Ltd (688683.SH) plans to launch an employee stock ownership plan in 2025.
Hubei Jianxin Chemical (300107.SZ) controlling shareholder and concerted action person Huang Jiqin plans to reduce their shareholding by no more than 0.14%.
HORIZONROBOT-W (09660) has awarded the equivalent of 86,775,100 shares of Class B common stock as a reward.
Guangdong Leary New Material Technology Co.,Ltd (688683.SH) plans to launch an employee stock ownership plan in 2025.
RECOMMEND
Anti-Overcompetition Drive Takes Hold Across Multiple Chinese Industries
04/07/2025
Bank of England Governor: Rise of Stablecoins May Undermine Confidence in National Currencies
04/07/2025
What the Passage of the “Big and Beautiful Act” Means for Americans: Gains and Losses Across Demographics
04/07/2025
